Published in Science · View the paper (DOI)
The authors argue that intranasal COVID-19 vaccines could provide additional layers of protection by eliciting immunoglobulin A and resident memory cells in the nasal passages. An ideal vaccination strategy may consist of an intramuscular vaccine combined with an intranasal booster, offering a dual approach to combat respiratory viruses.
Coverage from 2 institutions
- A case for intranasal COVID-19 vaccinations American Association for the Advancement of Science (AAAS) · Jul 22, 2021 · first to report
- Advantages of intranasal vaccination against SARS-CoV-2 University of Alabama at Birmingham · Jul 23, 2021